ImmuneOnco Biopharma
Shanghai · Founded 2015
About ImmuneOnco Biopharma
ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells.
Company Facts
- Founded: 2015
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $177.3M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2024)
- Ticker: hkg:1541
- Website: http://immuneonco.com/
- Phone: +86-21-58356573
Industries & Categories
Biopharma, Biotechnology, Health Care
Canonical: https://fsome.com/organization/immuneonco-biopharma-82258 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.